The ROE (Return on Equity) of Adaptimmune Therapeutics PLC (ADAP) is -597.64%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -597.64% |
| 2023-12-31 | -288.19% |
| 2022-12-31 | -202.03% |
| 2021-12-31 | -76.74% |
| 2020-12-31 | -38.13% |
| 2019-12-31 | -110.98% |
| 2018-12-31 | -38.68% |
| 2017-12-31 | -34.55% |
| 2016-12-31 | -43.09% |
| 2015-06-30 | -9.19% |